Search
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances
This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS).
This is an extensive and comprehensive...
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the...
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it...
Emerging Trends in Drugs, Addictions, and Health
Emerging Trends in Drugs, Addictions, and Health is a new international journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addiction and associated health phenomena.
The Journal has a...
New psychoactive substances: A review and updates
New psychoactive substances (NPS) are a diverse group of substances that are linked with a number of health and social harms on an individual and societal level. NPS toxicity and dependence syndromes are recognised in primary care...
UNODC Early Warning Advisory on New Psychoactive Substances
The rapid emergence of a large number of New Psychoactive Substances on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social...
New psychoactive substances (NPS)
Overview
A new psychoactive substance (NPS) is defined as 'a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat...
International Collaboration Activities: Which role for ECMAPS in tackling global health challenges? - Sophia Achab, Day 5, 11:00-12:31
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 16th May, 2022
Presentation:
- International Collaboration Activities: Which role for ECMAPS in tackling global health challenges...
The Effectiveness of Telemedicine to Prevent Relapse among a Clinical Sample of Substance-Use Disorder Patients: an Experience from a Developing Country during the COVID-19 Pandemic - Kristiana Siste, MD, PhD, Day 5, 11:00-12:31
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 16th May, 2022
Presentation:
- The Effectiveness of Telemedicine to Prevent Relapse among a Clinical Sample of Substance-Use...
Irregular Migration and Drug Trafficking: Assessing the Prevalence among Identified Female Migrant Returnees in Nigeria - Daniel Ikenna Molobe, Day 4, 15:30-16:57
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 15th May, 2022
Presentation:
- Irregular Migration and Drug Trafficking: Assessing the Prevalence among Identified Female Migrant...
The Hidden Costs of Big Tobacco
The devastating impact of tobacco on the health of users is well known. In addition to the negative effects for the individual, there are significant economic and environmental consequences, which need to be considered when developing...
Innovative approach for smartphone applications to share trustworthy information on parenting and family skills – the scaling of Children Immunization App (CIMA) in Middle East and Sub-Saharan Africa - Dr. Ziad El-Khatib, Day 4, 11:00-12:30
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 15th May, 2022
Presentation:
Innovative approach for smartphone applications to share trustworthy information on parenting and...
Keynote Speaker: Former U.S. Congressman: Patrick J. Kennedy, Day 3, Track 1, 08:30-09:00
ATI - Alternatives to Incarceration Systems: Treatment Interventions for Persons with Substance Use Disorders Who are in Contact with the Criminal Justice System, Day 2, Track 3, 14:00-15:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 13th May, 2022
Presentations:
- Integrating Treatment into the Criminal Justice System- Stakeholders' Perspective: Police -...
ATI - Alternatives to Incarceration Systems: Treatment Interventions for Persons with Substance Use Disorders Who are in Contact with the Criminal Justice System, Day 2, Track 3, 11:00-12:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 13th May, 2022
Presentations:
- Treating Persons with Substance Use Disorders in Contact with the Justice System - Charlotte...
اے ٹی آئی - قید کے نظام کے متبادل: مادہ کے استعمال کی خرابی والے افراد کے لئے علاج کی مداخلت جو فوجداری انصاف کے نظام کے ساتھ رابطے میں ہیں، دن 2، ٹریک 3، 09:00-10:30
نشے کی لت کے چیلنج کا سامنا کرنے کے لئے عالمی برادری کو متحد کرنے کے ایک حصے کے طور پر پیش کیا گیا، 13 مئی، 2022 کو ذاتی طور پر
پیشکشوں:
- قید کے متبادل کے لئے انٹرسیپشن ماڈل کا جائزہ - میلوڈی ہیپس
- مزید قانونی چارہ جوئی یا قید کے بدلے...
INEP Plus, Day 2, Track 2, 09:00-10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 13th May, 2022
Presentations:
- Quality of training modules in prevention – INEP, INEP Plus - Asst. Prof. Horálek Helena, Dr...
NRC Research Studies, Day 1, Track 2, 11:00 - 12:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 12th May, 2022
Presentations:
- Evaluation of: Overview Training on the Universal Prevention Curriculum for Substance Use (UPC)...